To promote the Progress of … useful Arts, by securing for limited Times to … Inventors the exclusive Right to their respective … Discoveries.” This statement in our Constitution makes science the basis of our patent law. As such, it is important for the courts (and the lawyers that argue before the courts) to understand not only the law that they are applying, but the science that is being protected by that law. Of course, this is easier said than done in light of the pace at which technology is advancing.
The recent decision by the Supreme Court in Association for Molecular Pathology v. Myriad Genetics, and the legal history that led to the decision, highlight the importance of knowing and understanding what is being protected. Central to this article is the court’s understanding of exactly what constituted “isolated DNA,” since patents now claiming isolated DNA may no longer be patent eligible or claims reciting “isolated DNA” or similar terms may be invalid.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]